Rheumatoid arthritis: a disease associated with accelerated atherogenesis

scientific article

Rheumatoid arthritis: a disease associated with accelerated atherogenesis is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.SEMARTHRIT.2005.03.004
P698PubMed publication ID16084219

P50authorJavier MartinQ55089349
P2093author name stringMiguel A Gonzalez-Gay
Carlos Gonzalez-Juanatey
P2860cites workActivation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylationQ22010150
P433issue1
P921main subjectrheumatoid arthritisQ187255
P304page(s)8-17
P577publication date2005-08-01
P1433published inSeminars in Arthritis and RheumatismQ15761553
P1476titleRheumatoid arthritis: a disease associated with accelerated atherogenesis
P478volume35

Reverse relations

cites work (P2860)
Q52684868A genetic association study of carotid intima-media thickness (CIMT) and plaque in Mexican Americans and European Americans with rheumatoid arthritis.
Q33923484A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis.
Q33304235Aminotransferases are associated with insulin resistance and atherosclerosis in rheumatoid arthritis
Q34450615Analysis of the interferon gamma (rs2430561, +874T/A) functional gene variant in relation to the presence of cardiovascular events in rheumatoid arthritis
Q37856782Angiogenesis as a therapeutic target in arthritis in 2011: learning the lessons of the colorectal cancer experience.
Q36151574Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy
Q42472471Anti-TNF-α therapy reduces retinol-binding protein 4 serum levels in non-diabetic patients with psoriasis: a 6-month prospective study.
Q38857820Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review
Q39274260Anti-inflammatory activity of fenugreek (Trigonella foenum-graecum Linn) seed petroleum ether extract
Q64095832Assessment of arterial stiffness variables in patients with rheumatoid arthritis: A mediation analysis
Q84089796Assessment of cardiovascular risk in rheumatoid arthritis: impact of the new EULAR recommendations on the score cardiovascular risk index
Q40445004Assessment of subclinical atherosclerosis in hidradenitis suppurativa
Q33730073Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients.
Q35617635Association of acid phosphatase locus 1*C allele with the risk of cardiovascular events in rheumatoid arthritis patients
Q35110147Asymptomatic atherosclerosis in egyptian rheumatoid arthritis patients and its relation to disease activity
Q41645180Atherosclerosis in rheumatoid arthritis
Q42083578Autoimmune rheumatic diseases
Q46635567Automated radiofrequency-based US measurement of common carotid intima-media thickness in RA patients treated with synthetic vs synthetic and biologic DMARDs.
Q38230867Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis
Q38993250Bioboosters in the treatment of rheumatic diseases: a comprehensive review of currently available biologics in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis.
Q34003845Blood monocyte subsets and selected cardiovascular risk markers in rheumatoid arthritis of short duration in relation to disease activity
Q36490766CARD8 rs2043211 (p.C10X) polymorphism is not associated with disease susceptibility or cardiovascular events in Spanish rheumatoid arthritis patients
Q41208538Can the ankle brachial pressure index (ABPI) and carotis intima media thickness (CIMT) be new early stage markers of subclinical atherosclerosis in patients with rheumatoid arthritis?
Q82594213Cardiac complications in rheumatoid arthritis in the absence of occlusive coronary pathology
Q26739070Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers
Q54524962Cardiovascular risk factor assessment: still an unmet need in chronic inflammatory diseases.
Q56907410Cardiovascular risk factors in primary Sjögren's syndrome: a case-control study in 624 patients
Q53101781Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than Coronary Artery Calcification Score to detect subclinical atherosclerosis in patients with rheumatoid arthritis.
Q37796382Carotid Intima Media Thickness in Rheumatoid Arthritis as Compared to Control Subjects: A Meta-Analysis
Q36809874Circulating endothelial progenitor cells as a link between synovial vascularity and cardiovascular mortality in rheumatoid arthritis
Q43581222Clinical significance of brachial flow-mediated dilation in patients with rheumatoid arthritis
Q37300823Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis
Q35557952Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease
Q35547019Coupling of Fcγ receptor I to Fcγ receptor IIb by SRC kinase mediates C-reactive protein impairment of endothelial function
Q90418225Diagnostic accuracy of digital X-ray radiogrammetry on hand bone loss for patients with rheumatoid arthritis
Q33593925Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration
Q33964367Do carotid artery diameters manifest early evidence of atherosclerosis in women with rheumatoid arthritis?
Q57178937Dynamic of changes in coronary artery calcification in early rheumatoid arthritis patients over 18 months
Q34578619Effect of peroxisome proliferator-activated receptor gamma agonist (pioglitazone) and methotrexate on disease activity in rheumatoid arthritis (experimental and clinical study).
Q46394312Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis
Q51106923Efficacy of computer-assisted pedicle screw insertion for cervical instability in RA patients.
Q83139265Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor-alpha blockade
Q41868896Enhanced cardiovascular risk in rheumatoid arthritis: elucidation, assessment, and management
Q41581710Features of cardiac remodeling in Patients with Acute Coronary Syndrome Complicated with Rheumatoid Arthritis.
Q36165202Genetic markers of cardiovascular disease in rheumatoid arthritis.
Q46792394Hematological and lipid profile evaluation of a hexane fraction of Costus afer leaves in arthritic rats
Q47408388High Expression of STAT3 in Subcutaneous Adipose Tissue Associates with Cardiovascular Risk in Women with Rheumatoid Arthritis
Q37699091High efficient and cost-effective screening method for diabetic cardiovascular risk
Q91715328Identification of a 3'-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study
Q39057277Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap.
Q37689920Independent associations of total and high molecular weight adiponectin with cardiometabolic risk and surrogate markers of enhanced early atherogenesis in black and white patients with rheumatoid arthritis: a cross-sectional study.
Q42755997Inflammation, endothelial function and atherosclerosis in rheumatoid arthritis
Q37427257Inflammatory arthritis: an overview for primary care physicians
Q46165782Insulin resistance without obesity induced by cotton pellet granuloma in mice
Q34388610Interaction between smoking and HLA-DRB1*04 gene is associated with a high cardiovascular risk in Brazilian Amazon patients with rheumatoid arthritis
Q41453068Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity
Q37699878Lack of association between ABO, PPAP2B, ADAMST7, PIK3CG, and EDNRA and carotid intima-media thickness, carotid plaques, and cardiovascular disease in patients with rheumatoid arthritis
Q36081372Lack of association between TLR4 rs4986790 polymorphism and risk of cardiovascular disease in patients with rheumatoid arthritis
Q82367308Lack of association between flow-mediated endothelium-dependent vasodilatation and biomarkers of endothelial dysfunction in patients with severe rheumatoid arthritis
Q58567872Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment
Q36182351Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis
Q28218493Lupus anticoagulant and ischemic myocardial microangiopathy in rheumatoid arthritis
Q37433269Marked independent relationship between circulating interleukin-6 concentrations and endothelial activation in rheumatoid arthritis
Q33869938Microvascular function is preserved in newly diagnosed rheumatoid arthritis and low systemic inflammatory activity
Q44729046NT-proBNP levels may be influenced by inflammation in active ankylosing spondylitis receiving TNF blockers: a pilot study
Q84072982Noninvasive assessment of impaired endothelial function in psoriasis
Q35588201On the HUNT for cardiovascular risk factors and disease in patients with psoriatic arthritis: population-based data from the Nord-Trøndelag Health Study
Q34128912Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis
Q38104641Overview of vasculitis and vasculopathy in rheumatoid arthritis--something to think about
Q90599771Possible Modulation of Vascular Function Measures in Rheumatoid Arthritis by Homocysteine
Q37296393Potential role of interleukin-18 in patients with rheumatoid arthritis-associated carotid intima-media thickness but not insulin resistance
Q36943007Predictors of Atherosclerosis in Ankylosing Spondylitis
Q44832625Predictors of endothelial dysfunction in patients with rheumatoid arthritis
Q36245670Predictors of new atherosclerotic carotid plaque development in patients with rheumatoid arthritis: a longitudinal study
Q40784903Prevalence of atherosclerosis in patients with inactive rheumatoid arthritis
Q36721103Primary Sjögren's Syndrome and the Risk of Acute Myocardial Infarction: A Nationwide Study
Q35842035Protective Role of the Interleukin 33 rs3939286 Gene Polymorphism in the Development of Subclinical Atherosclerosis in Rheumatoid Arthritis Patients.
Q92488644Protective effect of hydroxychloroquine on rheumatoid arthritis-associated atherosclerosis
Q24630655Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidity
Q37084274Psoriasis comorbidities
Q40184468Pulse wave velocity and augmentation index are not independently associated with carotid atherosclerosis in patients with rheumatoid arthritis.
Q34031160Regulation of foam cells by adenosine.
Q36830486Rheumatoid arthritis impacts on the independent relationships between circulating adiponectin concentrations and cardiovascular metabolic risk
Q87370747Rheumatoid arthritis: Obesity impairs efficacy of anti-TNF therapy in patients with RA
Q37691093SCORE and REGICOR function charts underestimate the cardiovascular risk in Spanish patients with rheumatoid arthritis
Q35035496SMAD3 rs17228212 gene polymorphism is associated with reduced risk to cerebrovascular accidents and subclinical atherosclerosis in anti-CCP negative Spanish rheumatoid arthritis patients.
Q40065441Sex and Cardiovascular Involvement in Inflammatory Joint Diseases
Q35257568Significant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis
Q38357522Simvastatin inhibits TLR8 signaling in primary human monocytes and spontaneous TNF production from rheumatoid synovial membrane cultures
Q43407682Single-nucleotide polymorphisms at the 9p21.3 genomic region not associated with the risk of cardiovascular disease in patients with rheumatoid arthritis
Q58767097Spectral Doppler and automated software-guided ultrasound assessment of bilateral common carotid intima-media thickness in spondyloarthritis: is there a correlation with clinical findings?
Q37027316Statin treatment for rheumatoid arthritis: a promising novel indication
Q34482096Study of association of CD40-CD154 gene polymorphisms with disease susceptibility and cardiovascular risk in Spanish rheumatoid arthritis patients.
Q34590834Subclinical atherosclerosis in patients with rheumatoid arthritis by utilizing carotid intima-media thickness as a surrogate marker.
Q36968832Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus
Q48092063Subclinical coronary artery disease in Asian rheumatoid arthritis patients who were in remission: a pilot study
Q52991178Suppression of inflammatory disease activity in rheumatoid arthritis is associated with improvements in retinal microvascular health.
Q29346986Sustained hypoxia promotes the development of a pulmonary artery-specific chronic inflammatory microenvironment
Q53583233Symmetric dimethylarginine (SDMA) serum levels in rheumatoid arthritis: correlations with insulin resistance and disease activity scores.
Q83844887Tc-99m sestamibi lower extremity muscle scan, is it a useful screening tool for assessment of preclinical atherosclerosis in rheumatoid arthritis patients?
Q46174533The 11q23.3 genomic region-rs964184-is associated with cardiovascular disease in patients with rheumatoid arthritis.
Q34388576The ZC3HC1 rs11556924 polymorphism is associated with increased carotid intima-media thickness in patients with rheumatoid arthritis
Q36477400The beneficial effects of Tai Chi exercise on endothelial function and arterial stiffness in elderly women with rheumatoid arthritis
Q51463578The effect of infliximab treatment on insulin resistance in patients with rheumatoid arthritis.
Q34582309The endothelium and its role in regulating vascular tone
Q57751065The influence of inflammation in the development of subclinical atherosclerosis in psoriatic arthritis: comment on ‘Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review’ by Jamnistkiet al
Q34713116The shared crosstalk of multiple pathways involved in the inflammation between rheumatoid arthritis and coronary artery disease based on a digital gene expression profile
Q36027291Therapeutic potential of folic acid supplementation for cardiovascular disease prevention through homocysteine lowering and blockade in rheumatoid arthritis patients.
Q40363705Treatments and in-hospital mortality in acute myocardial infarction patients with rheumatoid arthritis: a nationwide retrospective cohort study in Japan
Q28219857Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes
Q57307075Vascular endothelial growth factor A and cardiovascular disease in rheumatoid arthritis patients
Q37720349Whole body bone tissue and cardiovascular risk in rheumatoid arthritis
Q56966981¿Está incrementada la mortalidad cardiovascular en la artritis reumatoide? Posición en contra
Q34147976β-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release

Search more.